De Monitor - Pharming Professor schreef op 30 maart 2021 08:22:
Haegarda Available for Eligible Patients in Canada Starting April 6MARCH 26, 2021 Marta Figueiredo PhDBY MARTA FIGUEIREDO PHD IN NEWS.
"...............
In a separate release, the Canadian patient advocacy organization also announced that
Takeda’s Takhzyro (lanadelumab), another preventive HAE treatment, became available at low or no cost to eligible patients in Newfoundland and Labrador on March 17.
Eligible patients include those ages 12 and older who have experienced at least three HAE attacks within a one-month period and needed an injectable treatment.
Similar decisions have already occurred in other provinces, such as Alberta, Quebec, Ontario, British Columbia, New Brunswick, and Manitoba. ....................."
angioedemanews.com/2021/03/26/haegard...